INBX - Inhibrx Biosciences Inc.
IEX Last Trade
14.52
0.610 4.201%
Share volume: 145,333
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.91
0.61
4.39%
Fundamental analysis
26%
Profitability
25%
Dept financing
24%
Liquidity
75%
Performance
15%
Performance
5 Days
9.15%
1 Month
1.96%
3 Months
-8.20%
6 Months
-8.20%
1 Year
-8.20%
2 Year
-8.20%
Key data
Stock price
$14.52
DAY RANGE
N/A - N/A
52 WEEK RANGE
$10.80 - $18.95
52 WEEK CHANGE
-$0.08
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Mark Paul Lappe
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news